TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹2,224 Cr | ₹2,823 Cr | ₹2,238 Cr | ₹2,924 Cr | ₹3,299 Cr |
What is the latest Total Non-Current Liabilities ratio of TORRENT PHARMACEUTICALS ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹2,224 Cr |
Mar2023 | ₹2,823 Cr |
Mar2022 | ₹2,238 Cr |
Mar2021 | ₹2,924 Cr |
Mar2020 | ₹3,299 Cr |
How is Total Non-Current Liabilities of TORRENT PHARMACEUTICALS Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹2,224 Cr | -21.21 | |
Mar2023 | ₹2,823 Cr | 26.12 | |
Mar2022 | ₹2,238 Cr | -23.46 | |
Mar2021 | ₹2,924 Cr | -11.37 | |
Mar2020 | ₹3,299 Cr | - |
Compare Total Non-Current Liabilities of peers of TORRENT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TORRENT PHARMACEUTICALS | ₹107,291.4 Cr | 2.2% | -5% | 49.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹431,352.0 Cr | 1.7% | -4.7% | 48.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,265.0 Cr | 4.4% | 3.1% | 66% | Stock Analytics | |
CIPLA | ₹120,035.0 Cr | -0.9% | -1.7% | 17.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,286.0 Cr | -1% | -8.9% | 6.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹95,461.4 Cr | -1% | -4% | 48.4% | Stock Analytics |
TORRENT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TORRENT PHARMACEUTICALS | 2.2% |
-5% |
49.1% |
SENSEX | -1.9% |
-5% |
17.5% |
You may also like the below Video Courses